166 related articles for article (PubMed ID: 24770797)
1. Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still's disease.
Kim HA; Nam JY; Jung JY; Bae CB; An JM; Jeon JY; Kim BS; Suh CH
Clin Rheumatol; 2014 Jun; 33(6):865-8. PubMed ID: 24770797
[TBL] [Abstract][Full Text] [Related]
2. Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.
Jung JY; Suh CH; Sohn S; Nam JY; Kim HA
Clin Rheumatol; 2016 Aug; 35(8):1937-1942. PubMed ID: 27225247
[TBL] [Abstract][Full Text] [Related]
3. Germinal center kinase-like kinase (GLK/MAP4K3) expression is increased in adult-onset Still's disease and may act as an activity marker.
Chen DY; Chuang HC; Lan JL; Chen YM; Hung WT; Lai KL; Tan TH
BMC Med; 2012 Aug; 10():84. PubMed ID: 22867055
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of free interleukin-18 in adult-onset Still's disease.
Girard C; Rech J; Brown M; Allali D; Roux-Lombard P; Spertini F; Schiffrin EJ; Schett G; Manger B; Bas S; Del Val G; Gabay C
Rheumatology (Oxford); 2016 Dec; 55(12):2237-2247. PubMed ID: 27616144
[TBL] [Abstract][Full Text] [Related]
5. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 6: a possible marker of disease activity in adult onset Still's disease.
Scheinberg MA; Chapira E; Fernandes ML; Hubscher O
Clin Exp Rheumatol; 1996; 14(6):653-5. PubMed ID: 8978961
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-18 as a diagnostic marker of adult-onset Still's disease in older patients: a case report and review of the literature.
Usuda D; Furumura Y; Takeshima K; Sangen R; Kawai Y; Kasamaki Y; Iinuma Y; Kanda T
J Med Case Rep; 2018 Jul; 12(1):198. PubMed ID: 29986752
[TBL] [Abstract][Full Text] [Related]
8. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
[TBL] [Abstract][Full Text] [Related]
9. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum ferritin as a marker for adult Still's disease activity.
Schwarz-Eywill M; Heilig B; Bauer H; Breitbart A; Pezzutto A
Ann Rheum Dis; 1992 May; 51(5):683-5. PubMed ID: 1616341
[TBL] [Abstract][Full Text] [Related]
12. Still's disease in children and adults: a distinct pattern of acute-phase proteins.
Sobieska M; Fassbender K; Aeschlimann A; Bourgeois P; Mackiewicz S; Müller W
Clin Rheumatol; 1998; 17(3):258-60. PubMed ID: 9694067
[TBL] [Abstract][Full Text] [Related]
13. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
[TBL] [Abstract][Full Text] [Related]
14. Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.
Kim HA; Choi B; Suh CH; Han MH; Jung JY; Sayeed HM; Kim YW; Sohn S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106835
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity.
Sun Y; Wang Z; Chi H; Hu Q; Ye J; Liu H; Cheng X; Shi H; Zhou Z; Teng J; Yang C; Su Y
Clin Rheumatol; 2019 Nov; 38(11):3205-3210. PubMed ID: 31236746
[TBL] [Abstract][Full Text] [Related]
16. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease.
Kawashima M; Yamamura M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Miyawaki S; Amano T; Takeuchi T; Makino H
Arthritis Rheum; 2001 Mar; 44(3):550-60. PubMed ID: 11263769
[TBL] [Abstract][Full Text] [Related]
17. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
[TBL] [Abstract][Full Text] [Related]
18. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis.
Tian R; Chen X; Yang C; Teng J; Qu H; Liu HL
Front Immunol; 2021; 12():654811. PubMed ID: 33868298
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease.
Kawaguchi Y; Terajima H; Harigai M; Hara M; Kamatani N
Arthritis Rheum; 2001 Jul; 44(7):1716-7. PubMed ID: 11465725
[No Abstract] [Full Text] [Related]
20. Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
Guo Q; Zha X; Li C; Jia Y; Zhu L; Guo J; Su Y
Clin Rheumatol; 2016 Jan; 35(1):73-9. PubMed ID: 26547221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
